Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol
- PMID: 55532
- DOI: 10.1016/s0140-6736(76)91340-4
Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol
Abstract
In fifteen patients with hyperkalaemic familial periodic paralysis, inhalation of salbutamol alleviated hyperkaleamia and paralysis precipitated by exercise or oral administration of potassium chloride. In-vitro studies with rat soleus muscles indicated that the hypokalaemic effect of salbutamol is related to stimulation of the active coupled transport of sodium and potassium in muscle cells. Follow-up studies proved that the inhalation of salbutamol is a simple and adequate method for the treatment of the paralytic episodes in these patients.
Similar articles
-
[Favorable results of the treatment of the hyperkalemic form of periodic paralysis with salbutamol].Neurol Neurochir Pol. 1985 Sep-Oct;19(5):444-7. Neurol Neurochir Pol. 1985. PMID: 2421192 Polish.
-
Salbutamol inhalations suppress attacks of hyperkalemia in familial periodic paralysis.Monogr Hum Genet. 1978;10:62-5. doi: 10.1159/000401567. Monogr Hum Genet. 1978. PMID: 723906 No abstract available.
-
Letter: Salbutamol in hyperkalaemic familial periodic paralysis.Lancet. 1976 Feb 21;1(7956):427. doi: 10.1016/s0140-6736(76)90262-2. Lancet. 1976. PMID: 55692 No abstract available.
-
Familial periodic paralysis with hypokalaemia. Experimental and clinical investigations.Dan Med Bull. 1981 Mar;28(1):1-27. Dan Med Bull. 1981. PMID: 6263554 Review. No abstract available.
-
[Intermittent muscular paralyses and potassium metabolism].Nervenarzt. 1972 Jan;43(1):1-8. Nervenarzt. 1972. PMID: 4550932 Review. German. No abstract available.
Cited by
-
Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.Br J Clin Pharmacol. 1987 Feb;23(2):173-81. doi: 10.1111/j.1365-2125.1987.tb03026.x. Br J Clin Pharmacol. 1987. PMID: 3828194 Free PMC article.
-
Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.Eur J Clin Pharmacol. 1980 Feb;17(2):81-6. doi: 10.1007/BF00562614. Eur J Clin Pharmacol. 1980. PMID: 6102914
-
Regulation of muscle potassium: exercise performance, fatigue and health implications.Eur J Appl Physiol. 2021 Mar;121(3):721-748. doi: 10.1007/s00421-020-04546-8. Epub 2021 Jan 4. Eur J Appl Physiol. 2021. PMID: 33392745 Review.
-
Physical performance and serum potassium under chronic beta-blockade.Eur J Appl Physiol Occup Physiol. 1985;54(4):350-4. doi: 10.1007/BF02337177. Eur J Appl Physiol Occup Physiol. 1985. PMID: 2998786 Clinical Trial.
-
Targeted mutation of mouse skeletal muscle sodium channel produces myotonia and potassium-sensitive weakness.J Clin Invest. 2008 Apr;118(4):1437-49. doi: 10.1172/JCI32638. J Clin Invest. 2008. PMID: 18317596 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases